Q99816 (TS101_HUMAN) Homo sapiens (Human)
Tumor susceptibility gene 101 protein UniProtKBInterProSTRINGInteractive Modelling
Available Structures
21 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystallographic structure of human Tsg101 UEV domain in complex with a HEV ORF3 peptide |
Heteromer Q9YLR0; | 100 | 2×CL; 1×SO4; 50×NH4; | |||
| Crystal Structure of the Tsg101 UEV domain in complex with a human HRS PSAP peptide |
Heteromer O14964; | 100 | ||||
| Crystal structure of the Tsg101 UEV domain in complex with a HIV-1 PTAP peptide |
Heteromer Q72497; | 100 | ||||
| Crystal structure of the TSG101 UEV domain in complex with FA459 peptide |
Heteromer Q9YP46; | 100 | ||||
| Crystal structure of the TSG101 UEV domain in complex with FA258 peptide |
Heteromer Q9YP46; | 100 | ||||
| STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 PTAP "LATE DOMAIN" PEPTIDE, CNS ENSEMBLE |
Heteromer Q9IF21; | 100 | ||||
| Structure of the Tsg101 UEV domain in complex with a HIV-1 PTAP "late domain" peptide, DYANA Ensemb… |
Heteromer Q9IF21; | 100 | ||||
| Crystal structure of the Tsg101 UEV domain in complex with a HIV-1 Gag P7A mutant peptide |
Heteromer Q72497; | 100 | ||||
| Structure Of The Tsg101 UEV Domain In Complex With an Ebola PTAP late Domain Peptide |
Heteromer Q05128; | 100 | 1×SO4; | |||
| Structure of the human TSG101-UEV Domain in complex with the PTAP motif of the p19 gag protein of t… |
Heteromer P14078; | 100 | 1×SO4; | |||
| TSG101(UEV) domain in complex with Ubiquitin |
Heteromer P0CG48; | 100 | 2×CU; 2×SO4; | |||
| Solution-state NMR structural ensemble of human Tsg101 UEV in complex with K63-linked diubiquitin |
Heteromer P0CG47; | 100 | ||||
| Human ESCRT-I heterotetramer headpiece |
Heteromer Q96EY5; Q9H9H4; Q9UK41; | 100 | ||||
| Coiled-coil domain of tumor susceptibility gene 101 | homo-4-mer | 100 | 1×SO4; 6×CL; | |||
| Structure of the human TSG101-UEV domain in the P321 space group | monomer | 100 | 2×SO4; | |||
| Crystal Structure of the TSG101-UEV domain:space group P21 | monomer | 100 | 1×SO4; | |||
| Structure of the Tsg101 UEV domain | monomer | 100 | ||||
| Structure of the Tsg101 UEV domain | monomer | 100 | ||||
| Solution-state NMR structural ensemble of human Tsg101 UEV in complex with tenatoprazole | monomer | 100 | 1×4N1; | |||
| Crystallographic structure of human Tsg101 UEV domain | monomer | 100 | 1×SO4; | |||
| Crystal structure of Tsg101 UEV domain | monomer | 100 | ||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2f0r.2.A | monomer | 0.81 | 100.00 | |||
| 8otz.136.A | monomer | 0.56 | 21.10 | |||
| 8to0.461.A | monomer | 0.53 | 14.29 | |||
| 8hxx.1.A | monomer | 0.52 | 22.45 | |||
3 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 2p22.1.A | monomer | 0.57 | 22.92 | |||
| Isoform 2 | 8otz.135.A | monomer | 0.56 | 19.64 | |||
| Isoform 2 | 6rjx.1.A | monomer | 0.51 | 15.87 | |||